Clinical Trials Directory

Trials / Completed

CompletedNCT05520957

Early SARS-CoV-2 Tracheostomy

Early Tracheostomy in COVID-19 Critically Ill Patients: A Retrospective Case Series

Status
Completed
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
Cantonal Hospital Zenica · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Objective of this case series was to evaluate the characteristics of early COVID-19 tracheostomy and its effect on laboratory parameters. A series of 17 patients with COVID-19undergo surgical tracheostomy in our intensive care unit. Demographic parameters, duration indicators, and laboratory parameters before and after tracheostomy were analyzed in patients. Of the 17 patients, 4 were men and 13 women with a mean age of 59 years. The average length of total hospitalization were 12 days, the length of stay in intensive care were 10 days, the length of endotracheal intubation were 9 days, with the seventh day of tracheotomy. Neurological and thyroid diseases and withdrawal had a statistically significant difference (p \<0.05), with laboratory parameters without statistically difference. Critically ill COVID-19 patients undergoing early tracheostomy has a lower possibility of weaning from mechanical ventilation, and early tracheostomy itself has no significant effect on renal parameters, lactate and D-Dimer.

Conditions

Interventions

TypeNameDescription
PROCEDURETracheostomyWe collected data from all tracheotomised patients including age, sex, existing comorbidities, duration indicators (length of endotracheal intubation, day of tracheotomy, length of stay in the intensive care unit (ICU), and total length of hospital stay), respirator weaning marked with YES / NO. From the laboratory parameters, we analyzed: lactate, urea, creatinine, potassium and D-dimer. They were collected at two time intervals, before tracheotomy and after tracheotomy.

Timeline

Start date
2020-01-01
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2022-08-30
Last updated
2022-09-02

Locations

1 site across 1 country: Bosnia and Herzegovina

Source: ClinicalTrials.gov record NCT05520957. Inclusion in this directory is not an endorsement.